is metformin a glp-1 drug glp 1 or Comparing Glucagon‐like peptide‐1 receptor agonists versus in drug‐naive patients: nationwide cohort study - Sørensen - 2024 GLP-1 drugs have entered the

Defining context-specific vulnerabilities within this network may provide a unifying framework for ferroptosis-based therapeutic strategies in cancer

Many free tools exist, from Canva to GIMP

DL: Writing review & editing, Writing original draft

Ready to take the plunge

Key benefits for perimenopausal women: Targets visceral and subcutaneous fat accumulation that tends to increase as estrogen declines and metabolism slows Does not affect blood sugar or cause stimulant-related side effects such as anxiety or elevated heart rate Supports fat loss while preserving lean muscle tissue, important for maintaining metabolic rate during hormonal transition Administration method: Subcutaneous injection into abdominal fatty tissue, typically 2 inches from the navel